Bernstein Initiates Coverage of Novo Nordisk (NVO) With an Underperform Rating

Corroborated by 2 sources from 2 publishers

globalgeneral1d ago

TL;DR

Reports differ across sources; according to finance.yahoo.com, in another development, Novo Nordisk A/S (NYSE:NVO) announced on March 19 that the US Food and Drug Administration has approved Wegovy® HD to reduce excess body weight and maintain weight reduction long-term.

Sources